Airborne particulates and hospital admissions for cardiovascular disease: a quantitative review of the evidence. by Morris, R D
Environmental Health Perspectives • VOLUME 109 | SUPPLEMENT 4 | August 2001 495
The possibility that exposure to airborne
particles can contribute to cardiovascular
morbidity and mortality has generated a
steady ﬂow of published papers over the past
decade. Recently, this has risen to ﬂood pro-
portions, mainly because of the emergence
and the growing capacity of tools to conduct
time–series studies using health outcomes
data abstracted from records collected for
other purposes. 
These health outcomes can be grouped
according to the type of health event being
measured and the specific disease category
being evaluated. Most published studies con-
sider either measures of mortality or measures
of morbidity. Mortality data were particularly
important for early time–series studies because
of their routine availability and the lack of
ambiguity in death as a health end point.
However, data related to morbidity are poten-
tially more sensitive for time–series studies
because they involve greater numbers of sub-
jects. The only routinely and reliably collected
data relevant to cardiovascular morbidity in
the United States are derived from administra-
tive medical data sets (i.e., billing records) of
hospitalizations for speciﬁc hospitals or metro-
politan areas. Records of outpatient physician
contacts are not routinely available, and even
where they are, they tend to provide less com-
plete and accurate information than inpatient
records. Studies of the temporal relationship
between hospitalizations for cardiovascular
disease and the presence of ambient particu-
late air pollution were the focus of this study. 
Early studies of the relationship between
exposure to particles and cardiovascular dis-
ease relied on measures such as black smoke
or total suspended particulates. Those cruder
measures of particle exposure lack the speci-
ficity and physiologic relevance of measures
of speciﬁc particle groups, particularly partic-
ulate matter smaller than 10 µm or 2.5 µm
(PM10 or PM2.5, respectively). I limited this
review to studies that used size-speciﬁc mea-
sures of particles. In most cases, the studies
have relied on single monitoring stations with
daily pollutant measures as a surrogate for
individual exposures. 
Through a MEDLINE search for all
papers published before August 2000 that
considered PM10 or PM2.5 exposure and car-
diovascular disease together with a review of
references listed in those articles, I identiﬁed
12 published studies of hospital admissions
for cardiovascular disease (1–12). These
studies are listed in Table 1. Although
time–series studies seem to have taken on a
numbing sameness, no two studies have used
exactly the same method, and the differences
among studies have major implications for
their interpretation. Speciﬁcally, these studies
differ with respect to the health outcome or
outcomes considered; the measure of particle
exposure, including the consideration of time
lags between exposure and outcome; and the
covariates considered in the analysis.
In the following sections of this paper, I
consider the impact of these characteristics on
study results through a series of tables. Table
2 lists results pertaining to all cardiovascular
admissions with respect to PM10 exposure
without adjustment for co-pollutants.
Succeeding tables provide results for speciﬁc
cardiovascular diagnoses, results after adjust-
ment for co-pollutants, and effects associated
with subfractions of PM10. This analysis pro-
vides some insight into how study results are
inﬂuenced by the speciﬁc relationships being
characterized and the methods used to deﬁne
those relationships.
The published studies have presented
results in a variety of formats and present
results with respect to many different expo-
sure ranges. Conversion to a standard range is
essential to any meaningful comparison of
results. For this reason, all results presented in
this review have been converted to indicate
the estimated percentage increase in hospital
admissions associated with a 10-µg/m3
increase in particulate matter. 
Studies of the Relationship
between PM10 Exposure and
All Cardiovascular Admissions
The results of studies that considered the
association between PM10 exposure and car-
diovascular disease admissions are presented
in Table 2 and stratified according to age
group. These results by themselves refute any
assertion of consistency among the observed
associations between exposure to particles and
hospital admissions. The effect size varies by a
factor of 5 or more within each age group. 
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The reasons for this variability in effect
size must involve some combination of
chance variation and the impact of differ-
ences among the study designs. Study design
could influence results either through actual
differences in the effect being measured or
through apparent differences arising as an
artifact of the methods used in data collec-
tion and analysis. The underlying effect of
exposure to particulate matter on cardiovas-
cular morbidity may differ among locations
because of local differences in the pollutant
mixture, factors inﬂuencing individual expo-
sure, or the characteristics of the population
at risk. Even if the underlying effect were
constant, the estimated effect could vary
because of the modeling approach including
the adjustment for potential confounders
and the consideration of time lags.
The major differences in consideration of
confounders involved the evaluation of co-
pollutants as discussed below. Approaches to
considering time lags included evaluation of a
range of values, evaluation of multiday aver-
ages of different durations and starting points,
some combination of these approaches, or no
consideration of time lags at all (i.e., a time lag
of zero days). 
Each approach has potential limitations.
Studies in which a single time lag is evaluated
without a clear prior reason for doing so will
not capture effects that occur at other times.
Conversely, in those studies that consider
multiple time lags the researchers often select
the one with the strongest effect. This
approach will tend to overestimate the effect
of exposure to the particles to the extent that
this effect is associated with a particular lag.
Of particular concern, when there is no
underlying effect, the theory of extreme value
distributions shows that this approach can be
expected to yield estimates of effect size with a
magnitude similar to those routinely reported
for particles (13). To test this relationship
empirically, I performed a simulation to esti-
mate the average effect size that would be
reported from studies that considered time
lags of 0–5 days and picked the maximum. A
simulation based on 1,000 repetitions of the
case in which the underlying effect had a true
mean of 0 and a standard deviation of 1 yields
an average predicted effect size of 1.3%.
The variability in these results makes it
difﬁcult to draw any meaningful conclusions
from the aggregated cardiovascular disease
data. The results suggest instead that we must
look at groups of studies with greater homo-
geneity in health outcomes and modeling
approaches. Therefore, as a first step, I con-




Although cardiovascular diseases share many
risk factors, particularly in chronic exposures
that increase the risk of underlying disease,
they do differ in the pathophysiology of acute
morbidity. Therefore, consideration of indi-
vidual disease groups may provide greater
insight into the possible mechanisms by
Table 2. Results from single pollutant models of PM10 and combined hospital admissions for cardiovascular disease.a
% Increase 
Study (ﬁrst author) Age range (years) Time lag (days) per 10 µg/m3 95% CI
Linn, 2000 (11)>  29 0 0.64 0.41,0.88
Burnett, 1997 (3) All 1–4 2.30 0.29,4.36
Prescott, 1998 (5) All 1–3 4.80 0.90,8.85
Wong, 1999 (7) All 0-2 0.60 0.20,1.00
Gwynn, 2000 (12) All 1 0.62 –0.36,1.61
Prescott, 1998 (5) 0–64 1–3 0.40 –2.63,3.53
Atkinson, 1999 (6) 0–64 0 1.10 0.41,1.81
Wong, 1999 (7)5  to 64 0-5 0.50 0.20,0.80
Moolgavkar, 2000 – LA (10)2 0–64 0 2.20 1.12,3.30
Linn, 2000-LA (11)3 0–64 0 0.50 0.08,0.92
Schwartz, 1997 (4)>  64 0 1.19 0.22,2.16
Prescott, 1998 (5)>  64 1–3 2.37 0.45,4.33
Atkinson, 1999 (6)>  64 0 0.50 –0.04,1.04
Wong, 1999 (7)>  64 0–5 0.80 –0.30,1.91
Schwartz, 1999 (8)>  64 0 0.98 0.72,1.25
Linn, 2000 (11)>  64 0 0.62 –0.36,1.61
Moolgavkar, 2000 (10)
LA > 64 0 1.60 0.59,2.62
Cook >  64 0 2.10 1.49,2.71
Maricopa > 64 0 –1.20 –3.51,1.17
Abbreviations: Cook, Cook County; LA, Los Angeles County; Maricopa, Maricopa County. 
aAbstracted from studies of the relationship between exposure to ambient particulates and day-to-day variation in counts of hospital-
izations for cardiovascular disease.
Table 1. Studies of the relationship between ambient particulates as PM10 or PM2.5 and day-to-day variation in counts of hospitalization for cardiovascular disease.
Outcome Particle Exposure periods Gaseous pollutants
Study (ﬁrst author) Location diagnoses size Lag (days) Average (days) NO2 CO O3 SO2 Meteorologic covariates
Schwartz, 1995 (1) Detroit, MI CHF, IHD PM10 0– x Temperature, humidity
Morris, 1997 (2) Chicago, IL CHF PM10 0– xxxxTemperature, wind chill, humidity
Burnett, 1997 (3) Toronto, Ontario,  CVD PM10, PM2.5 0–4 1–5 x x x x Temperature
Canada
Schwartz, 1997 (4) Tucson, AZ CVD PM10 0– x Temperature, humidity - S
Prescott, 1998 (5) Edinburgh, CVD PM10 0 or 1 1 or 3  0 0 0 0 Temperature, humidity
Scotland
Atkinson,1999 (6) London, England CVD PM10 1–3 Lagged 0–3 x x x x Temperature
Temperature - S
Wong, 1999 (7) Hong Kong CVD, CHF,  PM10 0–5 0–5 x x 0 Temperature, humidity - S
IHD, CVA
Schwartz, 1999 (8) Multiple cities CVD PM10 0– x Temperature, humidity
Burnett, 1999 (9) Toronto DSR, CHF, IHD,  PM10, PM2.5 0–4 1–5 x x x x Temperature
CVD, AMI, CVA
Moolgavkar, 2000 (10) Los Angeles, CA;  CVD, CVA PM10, PM2.5 0–5 – x x x x Temperature, humidity
Phoenix, AZ; 
and Chicago
Linn, 2000 (11) Los Angeles CVD, DSR, CHF  PM10 0– 0000Temperature with indicators for 
hot, cold and rainy days - S
Gwynn, 2000 (12) Buffalo, NY CVD PM10 0–3 – 0 0 0 0 Temperature, humidity
Abbreviations: AMI, acute myocardial infarction; O, pollutants speciﬁcally included in multivariate models; NO2, nitrogen dioxide; O3, ozone; S, stratiﬁcation by temperature or elated variable; SO2, sulfur
dioxide; x, pollutants speciﬁcally included in multivariate models.Particulates and hospital admissions for cardiovascular disease
which particulate matter might cause acute
symptomatic disease. 
The validity of considering specific
diagnostic groups could be diminished by
substantial inaccuracy or inconsistency in dis-
ease coding. Although there may be some
regional and international variability in dis-
ease coding, the accuracy of these codes is rel-
atively high for cardiovascular disease (14,15).
Furthermore, misclassification would be
likely to alter the effect size substantially only
if the variability in coding resulted in a pat-
tern of excluding cases related to patients’ sus-
ceptibility to the cardiovascular effects of
exposure to particulate air pollutants. Such
misclassification is plausible if, for example,
presence of associated respiratory disease
resulted in coding the respiratory disease as
the primary diagnosis in some areas but not
in others. This could result in different effect
sizes in different cities. However, there is no
evidence to suggest that such a systemic
misclassiﬁcation occurred.
Table 3 lists the estimates of the effect of
PM10 with respect to four categories of car-
diovascular disease: dysrhythmia (DSR), con-
gestive heart failure (CHF), ischemic heart
disease (IHD), and cerebrovascular accident
(CVA). Two approaches were used to pool
results. A random-effects model was used to
pool all relevant studies. Then, the single
study making the greatest contribution to
heterogeneity among studies (as determined
by its contribution to Cochran’s Q statistic)
was eliminated and the remaining studies
were pooled using a ﬁxed-effects model. 
If we pool the results for CHF, admis-
sions decrease by 1.6% [95% confidence
interval (CI): 0.4, 2.8%] per 10 µg/m3
increase in PM10. After elimination of the
anomalous result from Wong et al. (7), the
pooled effect drops to 0.8% (95% CI: 0.5,
1.2%), similar to the effect observed for IHD
[0.7% (95% CI: 0.4, 1.0%)]. 
The four studies that considered CVA as
an outcome provide little support for the
underlying existence of substantial risk of
CVA associated with PM10 (7,9–11). The
pooled effect from the three studies that pro-
vided data was 0.7% (95% CI: –0.2, 1.6%)
and this effect dropped to 0.2% (95% CI:
–0.4, 0.8%) when the outlying result from
Moolgavkar’s Cook County data was
dropped (10). Furthermore, Burnett et al. (9)
found a protective effect for CVA associated
with PM10 exposure but did not publish
numerical results. Inclusion of these results
would further reduce the pooled effect.
Although this indicates that PM10 exposure
is not associated with an increase in overall
hospital admissions for CVA, it is possible
that this is too broad a category, as it
includes hypertensive as well as occlusive
strokes. When Linn et al. (12) limited their
analysis to occlusive strokes, they found a
1.3% (95% CI: 0.7, 1.9%) increase in
admissions per 10 µg/m3 increase in PM10.
This appears consistent with the observed
increase in IHD and suggests that studies
including hypertensive strokes may underesti-
mate of the effect of PM10 exposure on CVA.
DSR was examined in only two studies,
with substantially different results. Because
the point estimates of the two studies do not
fall within each other’s confidence limits,
pooling them seemed inappropriate. These
studies do not provide sufﬁcient basis for any
conclusion as to the effects of PM10 on
conductive disorders of the heart.
In summary, CHF and IHD admissions
appeared to be associated with PM10 expo-
sure with an increase of approximately 0.7%
for an increase of 10 µg/m3 in the PM10. The
effect for DSR may have been of similar
magnitude, but the data are too limited to
draw ﬁrm conclusions. There appears to have
been no relationship between CVA admis-
sions and PM10 exposure, but the conclusion
might have been different if analyses were
limited to occlusive strokes. The observed
associations must be interpreted with cau-
tion. None of the results considered to this
point included a full adjustment for covari-
ates, particularly gaseous co-pollutants. No
conclusions relevant to causality should be




The factors associated with acute exacerbation
of cardiovascular disease generally involve
those that place acute stress on the heart or
increase the coagulability of the blood. They
can include short-term variations in diet,
compliance with medications, exertion, phys-
ical stress, infections, and acute psychologic
stress. Time–series studies have the advantage
over many other designs in that they limit rel-
evant confounders to those that have a tem-
poral correlation with air pollution. It is
conceivable that any of the factors could be
associated with exposure to particulate air
pollution by virtue of the patients’ relation-
ship to weekly schedules, holidays, and other
events related to the calendar. Adjustment for
these types of cyclic patterns in the data
should account for this source of confound-
ing. Toward this end, well-conducted studies
include an indicator for day of the week and a
surrogate for seasonality in statistical models.
Some studies have also included indicator
variables for periods of known inﬂuenza epi-
demics. After these adjustments, gaseous pol-
lutants and meteorologic factors remain the
important potential confounders. 
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Table 3. Results from single pollutant models of PM10 and hospital admissions for speciﬁc cardiovascular disease
groups.
Time lag  % Increase 
Study (ﬁrst author) Age range (years) (days) per 10 µg/m3 95% CI
Congestive heart failure
Schwartz, 1995 (1)>  64 0 0.99 0.37,1.61
Morris ,1997 (2)>  64 0 0.77 0.20,1.35
Wong, 1999 (7)a All 0–3 4.80 3.20,6.42
Burnett, 1999 (9) All 0–2 1.87 0.82,2.93
Linn, 2000 (11)>  29 0 0.40 –0.19,0.99
Pooled (random effects) 1.60 0.40,2.81
Pooled (ﬁxed effects)b 0.83 0.50,1.15
Ischemic heart disease
Schwartz, 1995 (1)>  64 0 0.56 0.16,0.96
Atkinson, 1999 (6)>  64 0 0.97 0.15,1.80
Atkinson, 1999 (6)0 –64 0 1.33 0.25,2.41
Wong, 1999 (7) All 0–3 0.70 –0.10,1.51
Burnett, 1999 (9)a All 0–1 1.62 1.04,2.20
Linn, 2000 (11) All 0 0.60 0.01,1.20
Pooled (random effects) 0.95 0.26,1.64
Pooled (ﬁxed effects)b 0.68 0.41,0.96
Cerebrovascular accident
Wong, 1999 (7) All 0–1 0.30 –0.50,1.11
Linn, 2000 (11)>  29 0 0.06 –0.43,0.55
Moolgavkar, 2000 (10)
LA > 20 0 0.59 –1.22,2.43
Cooka > 64 0 6.00 2.69,9.42
Maricopa > 64 0 0.50 –0.89,1.91
Pooled (random effects) 0.68 –0.24,1.61
Pooled (ﬁxed effects)b 0.18 –0.21,0.57
Dysrhythmia
Burnett, 1999 (9) All 0 1.63 0.57,2.70
Linn, 2000 (11) All 0 0.20 –0.39,0.79
aStudy with the greatest contribution to heterogeneity among studies as determined by Cochran’s Q statistic. bFixed effects models
were run after excluding the study making the greatest contribution to heterogeneity among studies.Morris
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Inclusion of gaseous pollutants in models
of exposure to particles and development of
cardiovascular disease is controversial because
of the co-linearity inherent among air pollu-
tants and the concern that multipollutant
models will artiﬁcially diminish the true effect
of exposure to particulates. Conversely, to the
extent to which the observed association of
cardiovascular disease and exposure to parti-
cles is simply a reflection of the correlation
between particles and these gaseous pollu-
tants, failure to consider these pollutants will
lead to inaccurate estimates of effect size. 
In the published studies, adjusting for
co-pollutants consistently reduced the PM10
effect, as summarized in Table 4. This
reduction ranged from 10 to 320%, depend-
ing on the study, the outcome, and the co-
pollutants considered. The reduction ranges
from 10 to 25% with an average of 18% in
the four analyses by Schwartz and co-workers
(1,4) whereas the adjustments performed by
three groups of researchers (2,3,9,10) pro-
duced reductions of at least 35% with an
average of 82% (after excluding the extreme
value of 320%). 
The reasons for this variation are not
clear. Possibly, it reﬂects differences between
the analytical methods used by Schwartz and
co-workers (1,4) and those used by the oth-
ers. None of Schwartz’s analyses includes a
full set of gaseous criteria pollutants. In his
study of eight cities, Schwartz (8) did not per-
form adjustments but instead presented the
magnitude of the PM10 effect as a function of
the correlation of PM10 with different co-pol-
lutants. He argued that the consistency of the
PM10 effect among cities with differing corre-
lations between PM10 and co-pollutants
demonstrates low likelihood that those pollu-
tants would drive the PM10 effect. This some-
what unorthodox approach to assessing
confounding yields an interesting observa-
tion, but it should be interpreted in light of
the relatively small magnitude of documented
PM10 effects together with the complex, non-
linear relationships among pollutants, meteo-
rologic variables and cardiovascular disease.
For example, the correlation between carbon
monoxide and PM10 during cold weather
(conditions when the association of carbon
monoxide with cardiovascular disease appears
to be strongest) (2) may be far more impor-
tant than the annual correlation. This sea-
sonal correlation may be lost in a simple
correlation for the entire study period.
In contrast to Schwartz’s assertions about
co-pollutants, Burnett et al. (3,9), Morris
and Naumova (2), and Moolgavkar (10) all
reported substantial reductions in the PM10
effect when gaseous pollutants were consid-
ered. Morris and Naumova included all co-
pollutants, while Moolgavkar evaluated two
pollutant models. Burnett used two different
approaches to considering the impact of co-
pollutants on the observed effect of exposure
to particles. One set of models used stepwise
regression to select a set of gaseous pollu-
tants for each health outcome using the
Akaike information criteria, then generated
a model based on those pollutants together
with specific particulate matter metrics (9).
Those results are presented in Table 5. In a
second set of analyses, he allowed all the pol-
lutants to compete equally in a stepwise
model (9). In the second approach, none of
the particulate measures was even included
in models for CHF or IHD. 
Other researchers considered co-pollutants
but did not present comparable numerical
results. Atkinson et al. (6) stated that the PM10
effect was reduced in all two-pollutant models,
particularly for sulfur dioxide but did not pro-
vide any numerical results. Wong’s considera-
tion of co-pollutants was limited to estimating
the PM10 effect when ozone and nitrogen
dioxide were elevated. The PM10 effect was
higher in both cases [1.7% (95% CI: 0.7,
2.8%) during high ozone and 0.7% (95% CI:
–0.5, 2.0%) during high nitrogen dioxide
Table 4. Results from models of PM10 and hospital admissions for specific cardiovascular disease groups after
adjustment for gaseous co-pollutants.
Co-pollutants
Age range Diagnosis % Increase  considered
Study (ﬁrst author) (years) group per 10 µg/m3 95% CI Effect ratio CO NO2 SO2 O3
Burnett, 1997 (3) All CVD –0.28 –2.64,2.14 –0.12 x x x x
Schwartz, 1997 (4)>  64 CVD 0.93 0.00,1.86 0.85 x
Moolgavkar, 2000 (10)
LA 20–64 CVD 0.70 –0.67,2.09 0.32 x
LA >  64 CVD –0.90 –2.24,0.46 –0.56 x
Cook > 64 CVD 0.90 0.19,1.61 0.43 x
Burnett, 1999 (9)a All DSR 1.04 0.64 x x
Schwartz, 1995 (1)>  64 CHF 0.74 0.12,1.37 0.75 x
Morris, 1997 (2)>  64 CHF 0.39 –0.20,0.98 0.50 x x x x
Burnett, 1999 (9) All CHF 0.59 0.32 x x
Schwartz, 1995 (1)>  64 IHD 0.50 0.06,0.93 0.89 x
Schwartz, 1995 (1)>  64 IHD 0.47 0.03,0.90 0.94 x
Burnett, 1999 (9) All IHD –0.12 –0.08 x x
Moolgavkar, 2000 (10)
LA > 64 CVA –1.10 –2.74,0.56 –2.20 x
Cook > 64 CVA 0.90 –0.03,1.84 0.15 x
x, includes co-pollutants included in the model. aBurnett et al. (9) did not include conﬁdence intervals in these analyses. The multi-
pollutant model was a stepwise model that considered all co-pollutants for inclusion. 
Table 5. Results from single pollutant models of the association of PM2.5 with admissions for speciﬁc disease groups
and overall cardiovascular admissions both before and after adjustment for co-pollutants.
Effect ratio
Age Particle Diagnosis % Increase  Relative  Relative to 
Study (ﬁrst author) (years) size group per 10 µg/m3 95% CI to PM10 single pollutant
Burnett, 1997 (3) All PM2.5 CVD 2.81 –0.25,5.97 1.22
Moolgavkar, 2000 (10)
LA 20–64 PM2.5 CVD 1.40 0.73,2.08 0.64
LA > 64 PM2.5 CVD 1.70 1.00,2.40 1.06
Burnett, 1997 (3) All PM2.5
a CVD –0.64 –4.33,3.20 2.27 –0.23
Moolgavkar, 2000 (10)
LA 20–64 PM2.5
a CVD 0.90 –0.08,1.89 1.29 0.64
LA > 64 PM2.5
a CVD 0.30 –7.77,9.08 –0.33 0.18
LA 20–64 PM2.5 CVA 0.40 –0.90,1.72 0.67
LA > 64 PM2.5 CVA 0.60 –0.30,1.51 1.20
LA >  64 PM2.5
a CVA –0.30 –1.47,0.88 0.27 –0.50
Burnett, 1999 (9) All PM2.5 DSR 2.38 0.77,4.02 1.46
All PM2.5
a DSR 1.36 b 1.32 0.57
All PM2.5 CHF 2.58 0.76,2.58 1.38
All PM2.5
a CHF 0.53 0.90 0.21
All PM2.5 IHD 3.14 2.12,4.18 1.94
All PM2.5
a IHD 0.90 –7.31 0.29
Burnett, 1997 (3) All PM10–2.5 CVD 3.27 1.38,5.19 1.42
All PM10–2.5
a CVD –0.64 –1.37,0.11 2.27 –0.19
Burnett, 1999 (9) All PM10–2.5 DSR 2.02 –0.09,4.17 1.24
All PM10–2.5
a DSR 1.36 1.31 0.67
All PM10–2.5 CHF 3.08 1.18,5.01 1.65
All PM10–2.5
a CHF 1.35 2.29 0.44
All PM10–2.5 IHD 1.48 0.52,2.45 0.91
All PM10–2.5
a IHD –0.13 1.07 –0.09
aAdjusted for co-pollutants. bBurnett et al. (9) did not provide conﬁdence intervals for results of multipollutant models.Particulates and hospital admissions for cardiovascular disease
compared to 0.6% in the baseline model],
suggesting a possible interaction between
PM10 and ozone. 
Overall, these results indicate that the con-
founding effect of other pollutants can explain
a portion of the observed association between
particles and cardiovascular disease, potentially
a major portion. Given the relationship among
these pollutants, fully isolating this confound-
ing effect will be extremely difﬁcult. Perhaps
ongoing analyses looking at large numbers of
cities will shed further light on this controversy. 
Consideration of Temperature
Meteorologic factors are key covariates to
consider in time–series studies and all the
studies included in this analysis made some
effort to do so. Temperature is chief among
these weather-related variables considered in
the studies. There is substantial evidence that
extreme temperatures, particularly low tem-
peratures, substantially increase the risk of
acute cardiac events (16–18). A full consider-
ation of temperature in a time–series analysis
should take into account this U-shaped rela-
tionship. In addition, there is some evidence
in studies of other relationships between air
pollution and cardiac events that temperature
may act as an effect modiﬁer (19–21).
All studies listed in Table 1 included
adjustments for temperature. In most cases,
consideration of temperature was limited to
including it as a covariate. Most studies
sought to include the nonlinear nature of this
association by using either a polynomial
model or some form of piecewise model for
temperature. Because of the clear evidence of
increased cardiovascular morbidity during
extreme weather, particularly cold weather,
the potential interaction between PM10 and
temperature is of interest. 
A small number of studies considered this
interaction using a variety of approaches. In
London, England, Atkinson et al. (6) found
that the PM10 effect was strongest in the low-
est temperature tertile but did not provide
numerical details of their analysis. In Hong
Kong, Wong et al. (7) found that the effect of
PM10 disappeared during the cold season,
but, in this tropical climate, the cold season is
the more comfortable time of year. In
Tucson, Arizona, Schwartz (4) found that the
PM10 effect was reduced during periods of
warm temperature, but not significantly so.
In Los Angeles, California, Linn et al. (11)
found that the PM10 effect was stronger in
winter than in spring for CVD [0.96 (95%
CI: 0.48, 1.43) vs –0.3 (95% CI: –1.0,
0.42)]. The effect for CVA was stronger in
summer than in winter [1.2 (95% CI: –0.6,
3.2) vs –0.2 (95% CI: –1.2, 0.81)], but the
statistical power was clearly limited with
respect to CVA. None of those studies was
conducted in a city with severe winters and
only one was conducted in a temperate
climate. Given the known relationship
between cold temperatures and cardiovascular
disease, the possibility of increased effects in
winter warrants further investigation.
Effect of Particle Size
Data on the effect of PM2.5 were limited. The
only two cardiovascular disease morbidity
studies that considered this association explic-
itly yielded inconsistent results. The single-pol-
lutant models, particularly those of Burnett
and co-workers (3,9), suggested that PM2.5
might have a greater effect than PM10. For the
combined CVD admissions, the ratio of the
PM2.5 effect to the PM10 effect ranged from
0.67 to 1.65 for the single-pollutant models.
This was even clearer from the analysis of spe-
ciﬁc outcomes by Burnett which yielded the
effect ratios ranging from 1.38 to 1.94.
Surprisingly, Burnett and co-workers (3,9) also
found that the effect for coarse fraction (PM10
minus PM2.5) was greater than for the PM10
alone when he looked at speciﬁc cardiovascular
outcomes. In almost all cases, adjustment for
co-pollutants dramatically reduced the effect
size with reductions ranging from 33 to 150%.
These results clearly support efforts to consider
the ﬁne particle fraction in future studies and
provide further evidence of the importance of
considering co-pollutants in these studies.
Summary
Time–series studies consistently show that
PM10 is associated with overall hospital
admissions for cardiovascular disease, but a
careful review suggests that analyses at this
level of aggregation do not accurately charac-
terize the relationship. The magnitude of this
effect is highly variable and depends on the
speciﬁc disease category being considered, the
time lag used in the analysis, and the role of
co-pollutants.
These studies were inconsistent with
respect to the choice of time lags used in the
analysis. Selecting the time lag with the maxi-
mum effect could result in an overestimation
of the true effect size. This is evident in a
comparison of studies that depended on post
hoc rather than a priori selection of the time
lag to be considered. In two of three age
groups for combined cardiovascular disease
and in three of four categories for speciﬁc dis-
eases, the largest effect was associated with
studies using post hoc selection of time lags.
It would be preferable for researchers to base
the selection of time lag or time lags on a pri-
ori hypotheses. To the extent possible, selec-
tion of time lag should be based on an
understanding of the physiologic basis for the
adverse cardiovascular effect of air pollutants. 
Perhaps the greatest area of confusion
and controversy related to the published
studies involves adjustment for co-pollutants.
Most researchers find that adjustment for
co-pollutants tends to substantially reduce
the effect of particles, but the importance of
this reduction is controversial. Opinions
range from the perspective that the PM10
effect may be entirely the result of co-pollu-
tants and that PM10 is simply a surrogate for
these pollutants (10,22) to the assertion at
the other extreme that the PM10 effect is
independent of co-pollutants (8). It is essen-
tial that future studies consider co-pollutants
in an effort to shed further light on this
apparent inconsistency.
Other covariates may also influence the
relationship between PM10 and cardiovascu-
lar morbidity. Speciﬁcally, these studies sug-
gest that either high or low temperature may
modify the association of PM10 with hospital
admission for cardiovascular disease. This
interaction should also be considered in
future studies. Temperature may also interact
with other covariates, particularly carbon
monoxide. Failure to consider these inter-
actions may result in inaccurate estimates of
the PM10 effect.
All persons represented by individual
hospital admissions have serious underlying
cardiovascular disease. It is likely that most of
them would eventually be admitted to the
hospital for acute disease. An association
between air pollution and cardiovascular dis-
ease, to the extent that it is causal, means that
the acute stress of air pollution either led to
hospital admissions that would never have
occurred otherwise or only influenced the
timing of hospital admissions that would
have occurred without a change in air quality.
This is essentially the same issue that has been
evaluated as a harvesting effect in the mortal-
ity studies. The extent to which the particle
effect reﬂects a simple short-term shift in the
timing of admissions has a major impact on
any assessment of the public health impact of
these pollutants. None of these morbidity
studies explicitly considered the effect of
harvesting. Future studies should do so.
Future research on the association
between particulates and acute cardiovascular
disease should focus on speciﬁc cardiovascular
outcomes and should consider four key ques-
tions: a) To what extent do co-pollutants
explain this association? b) Do temperature or
other seasonal factors modify the particle
effect and how might their interaction with
other covariates inﬂuence the estimated parti-
cle effect? c) Do particle size and chemistry
inﬂuence this relationship? d) To what extent
does the observed effect reﬂect “harvesting” of
pending admissions?
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